Where do Cullinan Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-44%-12.0pp	-32.1%-1.1pp	-31%—	——
Return on assets	-41.1%-10.8pp	-30.3%-1.0pp	-29.3%—	——
Return on invested capital	-58%-12.7pp	-45.4%+6.1pp	-51.5%—	——
Liquidity
Current ratio	10.2×-3.3×	13.5×-3.5×	17.1×-4.0×	21.1×-4.2×
Quick ratio	10.2×-3.3×	13.5×-3.5×	17.1×-4.0×	21.1×-4.2×
Cash ratio	2.3×-0.4×	2.7×-0.8×	3.5×-3.4×	6.9×+1.9×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$1.14B+151%	$709.21M+62.6%	$436.07M-9.7%	$482.67M-29.6%
Enterprise value	$1.06B+181%	$628.36M+84.1%	$341.23M+2.9%	$331.53M-47.1%
Price / book	1.5×+0.3×	1.2×+0.2×	1×+0.1×	0.9×-0.7×
Earnings yield	-19.5%+20.0pp	-23.6%+11.5pp	-35.1%—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Cullinan Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.